Wu Z N, Chan C L, Eastman A, Bresnick E
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03756.
Cancer Res. 1992 Jan 1;52(1):32-5.
A plasmid has been constructed in which the expression of human O6-methylguanine-DNA methyltransferase (MGMT) complementary DNA is driven by the Rous sarcoma virus promoter sequence. We had previously shown that transfection of this plasmid into Chinese hamster ovary (CHO) cells results in the expression of MGMT and in increased cellular resistance to N-methyl-N'-nitro-N-nitrosoguanidine and 1-(2-chloroethyl)-1-nitrosourea (CNU) but not N-nitroso-N-ethylurea (ENU). In the present study, the Rous sarcoma virus promoter-MGMT was transfected into DNA excision repair-deficient CHO UV41 cells to investigate the phenotype associated with MGMT expression in the absence of DNA excision repair. Both the UV41/MGMT and CHO/MGMT cells expressed similar levels of MGMT and exhibited a similar increased resistance to N-methyl-N'-nitro-N-nitrosoguanidine. The UV41 cells were 20-fold more sensitive to CNU than the wild-type CHO cells. Expression of MGMT increased the resistance to CNU about 6-fold in both cell lines, but the difference between the two cell lines attributable to the excision repair defect still persisted. The UV41 cells were 2- to 3-fold more sensitive than the wild-type CHO cells to the monofunctional alkylating agents 1-(2-hydroxyethyl)-1-nitrosourea and ENU, but the MGMT phenotype did not alter sensitivity. This suggests that alkylation at the O6 position of guanine has no role in cytotoxicity of ethylating agents and that monofunctional DNA damage has little role in the cytotoxicity of CNU. Since MGMT can prevent the formation of G-C interstrand cross-links formed by CNU, other excision repair-sensitive DNA adducts must play a major role in the sensitivity of UV41 cells to this bifunctional alkylating agent. These results suggest that DNA intrastrand cross-links may be major contributors to the cytotoxicity of CNU.
构建了一种质粒,其中人O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)互补DNA的表达由劳氏肉瘤病毒启动子序列驱动。我们之前已经表明,将该质粒转染到中国仓鼠卵巢(CHO)细胞中会导致MGMT的表达,并增加细胞对N-甲基-N'-硝基-N-亚硝基胍和1-(2-氯乙基)-1-亚硝基脲(CNU)的抗性,但对N-亚硝基-N-乙基脲(ENU)没有抗性。在本研究中,将劳氏肉瘤病毒启动子-MGMT转染到DNA切除修复缺陷的CHO UV41细胞中,以研究在没有DNA切除修复的情况下与MGMT表达相关的表型。UV41/MGMT和CHO/MGMT细胞均表达相似水平的MGMT,并表现出对N-甲基-N'-硝基-N-亚硝基胍相似的抗性增加。UV41细胞对CNU的敏感性比野生型CHO细胞高20倍。MGMT的表达使两种细胞系对CNU的抗性增加约6倍,但由于切除修复缺陷导致的两种细胞系之间的差异仍然存在。UV41细胞对单功能烷化剂1-(2-羟乙基)-1-亚硝基脲和ENU的敏感性比野生型CHO细胞高2至3倍,但MGMT表型并未改变敏感性。这表明鸟嘌呤O6位的烷基化在乙基化剂的细胞毒性中不起作用,并且单功能DNA损伤在CNU的细胞毒性中作用很小。由于MGMT可以防止由CNU形成的G-C链间交联,其他切除修复敏感的DNA加合物必定在UV41细胞对这种双功能烷化剂的敏感性中起主要作用。这些结果表明DNA链内交联可能是CNU细胞毒性的主要因素。